Outcomes and prognostic factors in thyroid cancer patients with cranial metastases: A retrospective cohort study of 4,683 patients

被引:12
|
作者
Hong, Yi-Wen [1 ]
Lin, Jen-Der [2 ]
Yu, Ming-Chin [1 ]
Hsu, Chih-Chieh [1 ]
Lin, Yann-Sheng [1 ]
机构
[1] Chang Gung Univ, Chang Gung Mem Hosp, Linkou Branch, Dept Surg, 5 Fuxing St, Taoyuan 333, Taiwan
[2] Chang Gung Univ, Chang Gung Mem Hosp, Linkou Branch, Div Endocrinol & Metab,Dept Internal Med, 5 Fuxing St, Taoyuan 333, Taiwan
关键词
Thyroid cancer; Brain metastasis; Skull metastasis; Radioiodine; Surgery; BRAIN METASTASES; FOLLOW-UP; DISTANT METASTASIS; SKULL METASTASIS; CARCINOMA; PAPILLARY; RADIOIODINE; MANAGEMENT;
D O I
10.1016/j.ijsu.2018.06.001
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Cranial metastasis of thyroid cancer is rare. The aim of this study was to analyse the clinical characteristics, treatments and outcomes of thyroid cancer patients with cranial metastasis and to identify the associated prognostic factors. Materials and methods: Between January 1977 and August 2017, a total of 4683 patients were histologically confirmed to have thyroid cancer. Among them, 25 patients (0.53%) were identified as having cranial metastases, and their medical records were reviewed. The Kaplan-Meier method with a log-rank test was performed with cancer-specific survival as the main outcome. Cox regression analysis was used to examine the potential prognostic factors influencing patient survival. Results: Of the 25 patients, 21 were female, and 4 were male. The median age at the time of diagnosis of cranial metastasis was 63 years. Sixteen patients had metastases to the brain, and nine patients had metastases involving the skull only. Papillary carcinoma and follicular carcinoma accounted for 84.0% of cases. Twenty-four cases (96.0%) had extracranial metastases at the time of diagnosis of cranial metastases. Twenty patients received surgery, and 4 patients received palliative radiotherapy. One patient received supportive care only. The median cancer-specific survival after the diagnosis of cranial metastases was 27 months. According to the Kaplan-Meier test, 3 factors had a significant impact on survival, the metastatic site, histological types and surgical resection. According to the Cox regression analysis, skull metastases (HR: 0.274, 95% CI: 0.083-0.904, p = 0.033) and surgical resection (HR: 0.134, 95% CI: 0.019-0.929, p = 0.042) were identified as independent prognostic factors for a better outcome. Conclusions: Surgical resection is the mainstay therapy for thyroid cancer patients with cranial metastasis. Cranial metastases involving the skull only are associated with a better outcome.
引用
收藏
页码:182 / 187
页数:6
相关论文
共 50 条
  • [21] Prognostic factors of patients with thyroid cancer and bone metastasis at presentation
    Yao, Zhaonong
    Yao, Yuhong
    Zhou, Xiaowei
    Shen, Shujia
    Hu, Xiaofeng
    Gao, Qian
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [22] Dynamic estimates of survival in patients with follicular thyroid cancer: a retrospective cohort study
    Ji, Xiaoyu
    Yu, Ruonan
    Sun, Wei
    Zhang, Ping
    Dong, Wenwu
    Zhang, Hao
    ENDOCRINE, 2025, 87 (02) : 627 - 634
  • [23] Clinical and prognostic role of detection timing of distant metastases in patients with differentiated thyroid cancer
    Albano, Domenico
    Panarotto, Maria Beatrice
    Durmo, Rexhep
    Rodella, Carlo
    Bertagna, Francesco
    Giubbini, Raffaele
    ENDOCRINE, 2019, 63 (01) : 79 - 86
  • [24] Surgical Management and Factors Affecting the Prognosis for Patients with Thyroid Cancer Spinal Metastases: A Retrospective Analysis of 52 Consecutive Patients from a Single Center
    Zhang, Dan
    Gong, Haiyi
    Shen, Mao
    Wang, Da
    Jiao, Jian
    Yang, Xinghai
    Liu, Tielong
    Wei, Haifeng
    Wu, Zhipeng
    Xiao, Jianru
    WORLD NEUROSURGERY, 2019, 129 : E330 - E336
  • [25] The significance and the predictive factors of microscopic lymph node metastasis in patients with clinically node negative papillary thyroid cancer: A retrospective cohort study
    Noda, Satoru
    Onoda, Naoyoshi
    Morisaki, Tamami
    Kashiwagi, Shinichiro
    Takashima, Tsutomu
    Hirakawa, Kosei
    INTERNATIONAL JOURNAL OF SURGERY, 2015, 20 : 52 - 57
  • [26] Long-term outcomes and prognostic factors of patients with lung metastases from differentiated thyroid cancer after radioiodine therapy in Japan
    Akatani, Norihito
    Wakabayashi, Hiroshi
    Kayano, Daiki
    Inaki, Anri
    Takata, Aki
    Hiromasa, Tomo
    Yamase, Takafumi
    Kunita, Yuji
    Watanabe, Satoru
    Mori, Hiroshi
    Saito, Shintaro
    Nakajima, Kenichi
    Kinuya, Seigo
    ENDOCRINE JOURNAL, 2023, 70 (03) : 315 - 322
  • [27] Prognostic factors for survival in colorectal cancer patients with brain metastases undergoing whole brain radiotherapy: multicenter retrospective study
    Koo, Taeryool
    Kim, Kyubo
    Park, Hae Jin
    Han, Sae-Won
    Kim, Tae-You
    Jeong, Seung-Yong
    Park, Kyu Joo
    Chie, Eui Kyu
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [28] The effects of radioiodine therapy on parathyroid function among patients with papillary thyroid cancer: a retrospective cohort study
    Fei, Yuan
    Qiu, Yuxuan
    Xing, Zhichao
    Zhao, Wanjun
    Su, Anping
    Zhu, Jingqiang
    ENDOCRINE, 2020, 70 (02) : 426 - 434
  • [29] Prognostic factors in patients with salivary gland malignancy: a retrospective cohort study
    Siddiqui, Moghira Iqbaluddin
    Iftikhar, Haissan
    Bhatti, Umar Farooq
    Ikram, Mubasher
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2020, 70 (09) : 1627 - 1629
  • [30] Prognostic factors determining survival in patients with node positive differentiated thyroid cancer: a retrospective cross-sectional study
    Gulcelik, M. A.
    Ozdemir, Y.
    Colakoglu, Kadri M.
    Camlibel, M.
    Alagol, H.
    CLINICAL OTOLARYNGOLOGY, 2012, 37 (06) : 460 - 467